| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/22/2005 | CN1207018C Medicine for treating leukemia |
| 06/22/2005 | CN1207012C Medicine for treating digestive system disease and tumor and preparation method thereof |
| 06/22/2005 | CN1207002C Antineoplastic composite and its prepn process and use |
| 06/22/2005 | CA2487098A1 Novel targets for obesity from fat tissue |
| 06/21/2005 | US6909014 Intermediates for the synthesis of ether compounds |
| 06/21/2005 | US6908948 Saturated nitrogen compounds, that bind to nucleic acids and generate chemical intermediates that splice the strands; prophylaxis of tumors and viral diseases |
| 06/21/2005 | US6908943 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/21/2005 | US6908942 Carbocyclic oxy amines such as 2,2-dimethyl-3-(4-fluorobenzyl) ether-4-methoxy-6-(4-methoxybenzyl)amino Benzopyran and libraries, used for prophylaxis of eating disorders induced by lipid peroxidation; antioxidants |
| 06/21/2005 | US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 06/21/2005 | US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors |
| 06/21/2005 | US6908920 Pyrimidine derivatives |
| 06/21/2005 | US6908918 Ketone spirocyclopropaneindene compounds; antineoplastic agents to inhibit tumor cell growth in vitro or in vivo; particularly effective against solid tumors and multi-drug resistant tumors |
| 06/21/2005 | US6908916 C-5 modified indazolylpyrrolotriazines |
| 06/21/2005 | US6908906 Crystalline forms of pyrimidine nucleoside derivative |
| 06/21/2005 | US6908900 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
| 06/21/2005 | US6908741 Receptor for advanced glycated endproducts (RAGE); solid phase synthesis; immunoassay |
| 06/21/2005 | US6908611 Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases |
| 06/21/2005 | CA2231143C Farnesyl transferase inhibiting 2-quinolone derivatives |
| 06/21/2005 | CA2161970C Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin |
| 06/21/2005 | CA2150576C Injectable taxane derivatives based compositions |
| 06/21/2005 | CA2118498C A novel anti-neoplastic cytokine |
| 06/17/2005 | CA2453687A1 Therapeutic composition containing at least diflomotecan and capecitabin e |
| 06/16/2005 | WO2005054299A1 A kind of polysaccharide, its preparation method and use |
| 06/16/2005 | WO2005054251A1 New cartharidic amine, demethyl cartharidic amine derivatives and their medicinal use |
| 06/16/2005 | WO2005054250A1 Tricyclacetalactonin, Preparation and Use there of |
| 06/16/2005 | WO2005054216A1 Novel anticancer agent “sulcoxin” |
| 06/16/2005 | WO2005054213A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 06/16/2005 | WO2005053724A1 Compositions and method for treatment of steroid/nuclear receptor-mediated diseases |
| 06/16/2005 | WO2005053690A1 Use of benzimidazole derivatives for the manufacture of a medicament for treating a cancer |
| 06/16/2005 | WO2005037928A3 Compounds for dual photodiagnosis and therapy |
| 06/16/2005 | WO2005021594A3 Minimally immunogenic variants of sdr-grafted humanized antibody cc49 and their use |
| 06/16/2005 | WO2005013899A9 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/16/2005 | WO2005002576A3 Imidazole derivatives and their use as protein kinases inhibitors |
| 06/16/2005 | WO2005002552A3 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 06/16/2005 | WO2005000235A3 NUCLEIC ACID SEQUENCES ENCODING AND COMPOSITIONS COMPRISING IgE SIGNAL PEPTIDE AND/OR IL-15 AND METHODS FOR USING THE SAME |
| 06/16/2005 | WO2004099782A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) |
| 06/16/2005 | WO2004094476A3 Compositions and methods relating to stop-1 |
| 06/16/2005 | WO2004071400A3 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity |
| 06/16/2005 | WO2004048565A9 Apoptosis-associated protein and use thereof |
| 06/16/2005 | WO2003012072A3 Monoclonal antibodies to activated erbb family members and methods of use thereof |
| 06/16/2005 | WO1990011078A8 Regional chemotherapy with 4-hydroperoxycyclophosphamide |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050131236 Central nervous ystem disorders; neurodegenerative disorders; muscle contraction; endocrine diseases |
| 06/16/2005 | US20050131227 Synthesis of temozolomide and analogs |
| 06/16/2005 | US20050131200 Biocompatability; polyphosphoester/polyphosphoramidate linkages; improved gene delivery into muscles; DNA vaccines |
| 06/16/2005 | US20050131062 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 06/16/2005 | US20050131061 Angiogenesis inhibitors |
| 06/16/2005 | US20050131060 Spirolaxine acts as active principle for treatment of those pathologies responding to activation of PPAR gamma receptor, such as acute malignant haemopathies. and Type 2 insulin-resistant diabetes |
| 06/16/2005 | US20050131059 Anti-cancer combinations |
| 06/16/2005 | US20050131047 cardiovascular disorders |
| 06/16/2005 | US20050131024 Antiinflammatory agents; autoimmune diseases; anticancer agents |
| 06/16/2005 | US20050131023 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori |
| 06/16/2005 | US20050131018 Acetylene derivatives as inhibitors of histone deacetylase |
| 06/16/2005 | US20050131009 Urea substituted imidazoquinolines |
| 06/16/2005 | US20050131005 4-azasteroid derivatives as androgen receptor modulators |
| 06/16/2005 | US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity |
| 06/16/2005 | US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents |
| 06/16/2005 | US20050130996 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 06/16/2005 | US20050130984 Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 06/16/2005 | US20050130981 Compounds |
| 06/16/2005 | US20050130980 Novel imidazopyrazines as cyclin dependent kinase inhibitors |
| 06/16/2005 | US20050130977 Inhibitors of akt activity |
| 06/16/2005 | US20050130967 3-Substituted-4-pyrimidone derivatives |
| 06/16/2005 | US20050130957 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medical products and processes for preparing them |
| 06/16/2005 | US20050130945 Preventing recurrence of breast cancer with atamestane and toremifene |
| 06/16/2005 | US20050130942 (E)-2,4,6-trimethoxystyryl-4-methoxy-3-aminobenzylsulfone for example; cancer, tumors, multiple sclerosis, Pagets disease; antibody conjugates; target receptor tyrosine kinases and which arrest the Ras/Raf/MEK/ERK kinase cascade |
| 06/16/2005 | US20050130935 Combination of a beta-2-adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 06/16/2005 | US20050130927 For treating neoplasm, hypoproliferation, hyperproliferation, degenerative and neurodegenerative diseases, ischaemia, immune system disorder, infectious disease, or metabolic dysfunction |
| 06/16/2005 | US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 06/16/2005 | US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer |
| 06/16/2005 | US20050130899 Tumor antigens |
| 06/16/2005 | US20050130886 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit |
| 06/16/2005 | US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 06/16/2005 | US20050130876 Use of substances for treating tumors |
| 06/16/2005 | US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 06/16/2005 | US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders |
| 06/16/2005 | US20050130221 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 06/16/2005 | US20050130195 Functional molecule and process for producing the same |
| 06/16/2005 | US20050130146 Histone deactylase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 06/16/2005 | US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening |
| 06/16/2005 | US20050130127 Coronavirus-like particles comprising functionally deleted genomes |
| 06/16/2005 | US20050129789 Enhance natural killer cells using plant extracts from fruits, apples |
| 06/16/2005 | US20050129784 Use of a chemically stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 06/16/2005 | US20050129736 Compositions and methods for treating or preventing diseases of body passageways |
| 06/16/2005 | US20050129717 Novel uses |
| 06/16/2005 | US20050129701 Antibody to latent membrane proteins and uses thereof |
| 06/16/2005 | US20050129698 Polypeptides (MBP1) capable of interacting with oncogenic mutants of the p53 protein |
| 06/16/2005 | US20050129689 Method for treatment of tumors using photodynamic therapy |
| 06/16/2005 | US20050129688 Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants |
| 06/16/2005 | US20050129667 treating leukemia or bone cancer by injecting a samarium comples of ethylenediaminetetramethanephosphonic acid and another chemotherapeutic agent; stem cell/bone marrow transplantation and/or restoration; patient is not subjected to total body irradiation |
| 06/16/2005 | US20050129657 Interferon-alpha induced gene |
| 06/16/2005 | US20050129613 Mixing radioactive Technetium ethylenedicystiene complex with N-[2-(1H-pyrrolylmethyl)]-N'-(4-penten-3on-2)-ethane-1,2-diamine, and incubating |
| 06/16/2005 | US20050129611 Drugs for the diagnosis of tissue reproductive activity or the treatment of proliferative diseases |
| 06/16/2005 | CA2548454A1 Medicament comprising recombinant antibody against chemokine receptor ccr4 |
| 06/16/2005 | CA2548173A1 Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof |
| 06/16/2005 | CA2547355A1 Animal models of pancreatic adenocarcinoma and uses therefor |
| 06/16/2005 | CA2547229A1 Glycosylated triketide delta lactones |
| 06/16/2005 | CA2547077A1 Dna damage repair inhibitors for treatment of cancer |
| 06/16/2005 | CA2547008A1 New class of gamma delta t cells activators and use thereof |
| 06/16/2005 | CA2546782A1 Pharmaceutical uses of bisphosphonates |